Literature DB >> 24083561

Treatment for hemophilia: recombinant versus plasma-derived coagulation factors - controversy and debate forever? An ethical medical challenge?

Antonio Liras1, Rebecca García-Trenchard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24083561     DOI： 10.1586/17474086.2013.834798

Source DB:  PubMed          Journal:  Expert Rev Hematol        ISSN： 1747-4094            Impact factor:   2.929


× No keyword cloud information.
  1 in total

Review 1.  “Go no Go” in plasma fractionation in the world’s emerging economies: still a question asked 70 years after the COHN process was developed!

Authors:  Thierry Burnouf; Jerard Seghatchian
Journal:  Transfus Apher Sci       Date:  2014-10       Impact factor: 1.764
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.